2023
Premature atherosclerosis: A review of current literature
Neifert A, Su D, Chaar C, Sumpio B. Premature atherosclerosis: A review of current literature. JVS-Vascular Insights 2023, 1: 100013. DOI: 10.1016/j.jvsvi.2023.100013.Peer-Reviewed Original ResearchRisk factorsAtherosclerotic diseaseClinical manifestationsGenetic predispositionTraditional atherosclerotic risk factorsHuman immunodeficiency virus (HIV) infectionNontraditional risk factorsActive antiretroviral therapyAtherosclerotic risk factorsImmunodeficiency virus infectionPeripheral arterial diseaseCerebral vascular diseasePremature atherosclerotic diseaseUnique risk factorsRecreational substance useAntiretroviral therapyAutoimmune conditionsDisease-associated lossMetabolic syndromeArterial diseasePremature atherosclerosisLipid derangementsMyocardial infarctionVascular diseaseVirus infection
2016
Systemic and cell-specific mechanisms of vasculopathy induced by human immunodeficiency virus and highly active antiretroviral therapy
Haser GC, Sumpio B. Systemic and cell-specific mechanisms of vasculopathy induced by human immunodeficiency virus and highly active antiretroviral therapy. Journal Of Vascular Surgery 2016, 65: 849-859. PMID: 26994951, DOI: 10.1016/j.jvs.2016.01.036.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusActive antiretroviral therapySmooth muscle cellsAntiretroviral therapyHIV patientsImmunodeficiency virusTraditional cardiovascular risk factorsMuscle cellsEndothelial cellsCardiovascular risk factorsChronic immune activationSerious cardiovascular eventsDevelopment of atherosclerosisVascular systemCardiovascular eventsVascular complicationsHIV medicationsChronic inflammationImmune activationMyocardial infarctionRisk factorsCell-specific mechanismsGeneral populationCholesterol metabolismCardiovascular pathology
2010
Meta-analysis of open versus endovascular repair for ruptured descending thoracic aortic aneurysm
Jonker FH, Trimarchi S, Verhagen HJ, Moll FL, Sumpio BE, Muhs BE. Meta-analysis of open versus endovascular repair for ruptured descending thoracic aortic aneurysm. Journal Of Vascular Surgery 2010, 51: 1026-1032.e2. PMID: 20347700, DOI: 10.1016/j.jvs.2009.10.103.Peer-Reviewed Original ResearchConceptsOpen repairThoracic aortic aneurysmEndovascular repairAortic aneurysmMyocardial infarctionMortality rateEndovascular thoracic aortic aneurysm repairThoracic aortic aneurysm repairAneurysm-related survivalCochrane Library CENTRALOpen surgical repairAortic aneurysm repairExcerpta Medica Database (EMBASE) databasesHigh mortality rateParaplegia rateTEVAR groupType of repairAdditional patientsAneurysm repairSurgical repairMean ageContemporary outcomesTreatment outcomesTEVARSmall series
2000
Tissue Plasminogen Activator: Biological and Physiological Relevance for Vascular Surgeons
Chang R, Kamal K, Sumpio B. Tissue Plasminogen Activator: Biological and Physiological Relevance for Vascular Surgeons. 2000, 1315-1323. DOI: 10.1007/978-1-4612-1190-7_103.Peer-Reviewed Original ResearchTissue-type plasminogen activatorThrombolytic therapyDeep venous thrombosisOcclusive vascular diseaseEfficacy of treatmentCerebrovascular accidentPulmonary embolismVenous thrombosisClinical outcomesMyocardial infarctionVascular diseaseVascular surgeonsHuman trialsEffective treatmentThrombolytic agentsPlasminogen activatorTherapyPhysiological relevanceTreatmentEndogenous propertiesEmbolismInfarctionThrombosisPatientsAgents